At the IGTP TODAY

News

- Innovation, Research

Progress in developing specific immunotherapies for type 1 diabetes

Researchers from IGTP and Ahead Therapeutics have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study recently published in the Journal of Autoimmunity examines the response of macrophages to this immunotherapy, serving as a preliminary step before clinical trials.

Innomed programme kicks off

The Innomed programme has been launched with the ambition of transforming the landscape of health innovation at the Can Ruti Campus, creating synergies between the public and private sectors. With a structured approach around three key axes - nurturing the culture of innovation, fostering project incubation, and facilitating cross-sector collaboration - Innomed aims to turn knowledge into action to achieve tangible impact on the healthcare community.

- Innovation

Nimble Diagnostics secures a €2.5 million grant from the EIC Accelerator programme

Nimble Diagnostics has been awarded a €2.5 million grant from EIC Accelerator, a funding programme of the European Innovation Council and SMEs Executive Agency (EISMEA). This spin-off from the Germans Trias i Pujol Research Institute (IGTP), the Polytechnic University of Catalonia - BarcelonaTech (UPC) and the University of Barcelona (UB), is among the 47 selected companies from 15 countries, chosen from a pool of 648 proposals.

Two projects from IGTP funded by ”la Caixa” Foundation to transition their innovative research from the laboratory to patients

The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.

- Innovation, Institutional

IGTP's Innovation Unit receives AENOR's R&D&I Certification

The certification body AENOR has accredited the Germans Trias i Pujol Research Institute (IGTP) for successfully implementing a research, development, and innovation (R&D&I) management system in accordance with the UNE 166002:2021 Standard. This certification is a guarantee of good practices, and confirms that the implementated R&D&I management system meets the statutory requirements.

Two IGTP groups lead a European analysis to understand key factors for digitalisation in practice environments

The research groups in Nursing Care (NURECARE) and Innovation, Health Economics and Digital Transformation (INEDIT) from the IGTP are leading the publication of the first report on the key factors for introducing digital technologies in professional nursing practice environments. Through this effort, professionals from the Germans Trias Hospital are participating for the first time in the design of a comprehensive analysis of the required changes, while also offering recommendations to ensure the success of any initiative aimed at incorporating these technologies into hospitals.

- Innovation, Success Stories

Hyposfix, a new medical device to improve paediatric urological surgeries, has been developed by researchers at Germans Trias Hospital, with support from IGTP

The expertise and innovation spirit of researchers at Germans Trias Hospital's Paediatric Surgery Service has resulted in a new medical device for the treatment of hypospadias: Hyposfix, a urological separator-fixator. This device, which will be launched to market soon, is the result of an idea and a project led at Germans Trias i Pujol Research Institute (IGTP).